搜索临床试验以:camrelizumab;Rivoceranib
总计438个结果
-
Lei Li招聘中宫颈癌 | 免疫疗法 | 生存结果 | 不良事件 | 局部晚期宫颈癌 | 放化疗 | 免疫检查点抑制剂 | 抗程序性细胞死亡受体 1 | Early Stage Cervical Cancer中国
-
Zhejiang Cancer HospitalZhejiang Provincial People's Hospital; Jinhua Municipal Central Hospital; Huizhou Municipal Central... 和其他合作者尚未招聘
-
Eye & ENT Hospital of Fudan UniversityChinese Academy of Medical Sciences招聘中
-
Yue HanJiangsu HengRui Medicine Co., Ltd.招聘中
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.邀请报名
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Sichuan Cancer Hospital and Research Institute招聘中
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Shanghai Zhongshan Hospital邀请报名
-
Beijing Chao Yang Hospital招聘中
-
Peking University尚未招聘
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中BCLC 分类中的 C 期肝细胞癌中国
-
Peking University Cancer Hospital & InstituteBeijing Nanjiao Cancer Hospital招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.未知
-
Tongji UniversityShanghai Pulmonary Hospital, Shanghai, China尚未招聘肺癌 | 卡瑞利珠单抗
-
Ruijin Hospital招聘中Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)中国
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.未知